Proteasome inhibition causes epithelial-mesenchymal transition upon TM4SF5 expression

Journal of Cellular Biochemistry

Volumn 112, Issue 3, 2011, Pages 782-792

  Kim, Jin Young ^a   Nam, Jae Kook ^a   Lee, Sin Ae ^b   Lee, Mi Sook ^b   Cho, Somi K ^c   Park, Zee Yong ^d   Lee, Jung Weon ^b   Cho, Moonjae ^a  

^a Jeju National University School of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Jeju National University   (South Korea)

^d Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Epithelial mesenchymal transition proteasome tetraspan transcription

Indexed keywords

MEMBRANE PROTEIN; SHORT HAIRPIN RNA; TRANSMEMBRANE 4 L SIX FAMILY MEMBER 5 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CELL ADHESION; CELL INTERACTION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN SYNTHESIS; RNA SYNTHESIS; UBIQUITINATION;

BETA CATENIN; CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CELL SURVIVAL; CYSTEINE PROTEINASE INHIBITORS; DOWN-REGULATION; ENZYME ASSAYS; EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCYTE GROWTH FACTOR; HUMANS; LEUPEPTINS; MEMBRANE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT PROTEINS; RNA; RNA INTERFERENCE; TRANSCRIPTION, GENETIC; UBIQUITINATION;

EID: 79951789064     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22954     Document Type: Article

References (32)

1. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. 2009. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119:1438-1449.
2. Adams J. 2003. The proteasome: structure, function, and role in the cell. Cancer Treat Rev 29(Suppl 1): 3-9. (Pubitemid 36626287)
3. Adams J. 2004. The development of proteasome inhibitors as anticancer drugs. Cancer Cell 5:417-421. (Pubitemid 38610244)
4. Baritaki S, Chapman A, Yeung K, Spandidos DA, Palladino M, Bonavida B. 2009. Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction. Oncogene 28:3573-3585.
5. Boyer B, Valles AM, Edme N. 2000. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 60:1091-1099.
6. Choi S, Oh SR, Lee SA, Lee SY, Ahn K, Lee HK, Lee JW. 2008. Regulation of TM4SF5-mediated tumorigenesis through induction of cell detachment and death by tiarellic acid. Biochim Biophys Acta 1783:1632-1641.
7. Dantuma NP, Lindsten K. 2010. Stressing the ubiquitin-proteasome system. Cardiovasc Res 85:263-271.
8. Daulny A, Geng F, Muratani M, Geisinger JM, Salghetti SE, Tansey WP. 2008. Modulation of RNA polymerase II subunit composition by ubiquitylation. Proc Natl Acad Sci U S A 105:19649-19654.
9. Ferdous A, Gonzalez F, Sun L, Kodadek T, Johnston SA. 2001. The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol Cell 7:981-991. (Pubitemid 32525745)
10. Gavert N, Ben-Ze'ev A. 2008. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med 14:199-209.
11. Guarino M, Rubino B, Ballabio G. 2007. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39:305-318. (Pubitemid 46897605)
12. Kalluri R. 2009. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 119:1417-1419.
13. Klimaschewski L, Hausott B, Ingorokva S, Pfaller K. 2006. Constitutively expressed catalytic proteasomal subunits are up-regulated during neuronal differentiation and required for axon initiation, elongation and maintenance. J Neurochem 96:1708-1717. (Pubitemid 43351628)
14. Lee SA, Lee SY, Cho IH, Oh MA, Kang ES, Kim YB, Seo WD, Choi S, Nam JO, Tamamori-Adachi M, Kitajima S, Ye SK, Kim S, Hwang YJ, Kim IS, Park KH, Lee JW. 2008. Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma. J Clin Invest 118:1354-1366. (Pubitemid 351500429)
15. Lee SA, Ryu HW, Kim YM, Choi S, Lee MJ, Kwak TK, Kim HJ, Cho M, Park KH, Lee JW. 2009. Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative. Hepatology 49:1316-1325.
16. Murata S, Yashiroda H, Tanaka K. 2009. Molecular mechanisms of proteasome assembly. Nat Rev Mol Cell Biol 10:104-115.
17. Muratani M, Tansey WP. 2003. How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol 4:192-201. (Pubitemid 36288041)
18. Muschel RJ, Gal A. 2008. Tetraspanin in oncogenic epithelial-mesenchymal transition. J Clin Invest 118:1347-1350. (Pubitemid 351500427)
19. Pickart CM. 2001. Mechanisms underlying ubiquitination. Annu Rev Biochem 70:503-533. (Pubitemid 32663902)
20. Rajkumar SV, Richardson PG, Hideshima T, Anderson KC. 2005. Proteasome Inhibition As a Novel Therapeutic Target in Human Cancer. J Clin Oncol 23:630-639. (Pubitemid 46224241)
21. Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, Hofler H, Becker KF. 2002. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol 161:1881-1891. (Pubitemid 35265545)
22. Saitoh M, Shirakihara T, Miyazono K. 2009. Regulation of the stability of cell surface E-cadherin by the proteasome. Biochem Biophys Res Commun 381:560-565.
23. Thiery JP. 2003. Cell adhesion in cancer. Comptes Rendus Physique 4:289-304. (Pubitemid 36623999)
24. Thiery JP, Acloque H, Huang RY, Nieto MA. 2009. Epithelial-mesenchymal transitions in development and disease. Cell 139:871-890.
25. Thiery JP, Sleeman JP. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142. (Pubitemid 43278296)
26. Tse JC, Kalluri R. 2007. Mechanisms of metastasis: epithelial-to- mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 101:816-829. (Pubitemid 47040864)
27. Tsukamoto T, Nigam SK. 1999. Cell-cell dissociation upon epithelial cell scattering requires a step mediated by the proteasome. J Biol Chem 274:24579-24584.
28. Wahab NA, Mason RM. 2006. A critical look at growth factors and epithelial-to-mesenchymal transition in the adult kidney. Interrelationships between growth factors that regulate EMT in the adult kidney. Nephron Exp Nephrol 104:e129-e134.
29. Xu J, Lamouille S, Derynck R. 2009. TGF-b-induced epithelial to mesenchymal transition. Cell Res 19:156-172.
30. Yang J, Weinberg RA. 2008. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14:818-829. (Pubitemid 351757205)
31. Zhang F, Laiho M. 2003. On and off: proteasome and TGF-b signaling. Exp Cell Res 291:275-281.
32. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC. 2004. Dual regulation of Snail by GSK-3b-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6:931-940. (Pubitemid 39359846)